AzTrials
AzTrials

Type I DiabetesEarly Phase 1DICENCT05160142

Diabetes Inspired Culinary Education

A Early Phase 1 study testing DICE in people with Type I Diabetes, run by Case Western Reserve University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to assess the feasibility and efficacy of a community-based culinary nutrition education program (Diabetes Inspired Culinary Education, DICE) on improving the diabetes management and dietary intake of 6-14 year old children with type I diabetes mellitus (TIDM). Read more about this study

Who is it for?
Ages 6 years and older
Conditions the study is for
Type I Diabetes
What is being tested?
DICE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteUnited States
Study dates
5 Sep 2019to 21 Nov 2019
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Children: 6-14 years old; diagnosed with type I diabetes within the past 5 years; English speaking
  • Adults: primary caregiver of a 6-14 year old child diagnosed with type I diabetes within the past 5 years; English speaking

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Dave's Grocery Store and Teaching Kitchen

    Cleveland, Ohio, 44103

Other trials in United States

About this study

The aim of this study is to assess the feasibility and efficacy of a community-based culinary nutrition education program (Diabetes Inspired Culinary Education, DICE) on improving the diabetes management and dietary intake of 6-14 year old children with type I diabetes mellitus (TIDM).

Conditions
Type I Diabetes
Being tested
DICE
Medical subject headings
Diabetes Mellitus, Type 1

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DICEBehavioural

    10-week culinary and nutrition education program for children with type I diabetes

Study groups in NCT05160142
Study groupRoleWhat they receive
InterventionExperimentalParticipate in the DICE program, which entails culinary and diabetes educational programming delivered weekly for 10 consecutive weeks.
Receives: Behavioral: DICE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. % Change in Hemoglobin A1c

    Blood glucose/diabetes management

    Measured: Baseline/pretest, 3 months/posttest

Secondary outcomes (13)
  1. Change in daily servings of fruit

    Daily fruit intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool

    Measured: Baseline/pretest, 3 months/posttest

  2. Change in daily servings of vegetables

    Daily vegetable intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool

    Measured: Baseline/pretest, 3 months/posttest

  3. Change in daily servings of whole grains

    Daily whole grain intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool

    Measured: Baseline/pretest, 3 months/posttest

  4. Change in daily servings of sugar-sweetened beverages

    Daily sugar-sweetened beverage intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool

    Measured: Baseline/pretest, 3 months/posttest

  5. Change in daily total caloric intake

    Daily caloric intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool

    Measured: Baseline/pretest, 3 months/posttest

  6. Change in primary caregiver body mass index (kg/m2)

    Assessment of weight status using calibrated stadiometer and electronic scale.

    Measured: Baseline/pretest, 3 months/posttest

  7. Change in child body mass index z-score

    Assessment of weight status using calibrated stadiometer and electronic scale.

    Measured: Baseline/pretest, 3 months/posttest

  8. Change in child blood pressure z-score

    Includes systolic and diastolic blood pressure z-scores

    Measured: Baseline, 3 months, 6 months, 9 months

  9. Change in child food preparation attitude, self-efficacy and frequency of involvement

    Scale 0-132 (higher score indicates more positive attitude, higher self-efficacy, greater frequency of involvement)

    Measured: Baseline/pretest, 3 months/posttest

  10. Change in child adherence to TIDM management regimen score

    Assessed via Diabetes Management Questionnaire - Scale of 14-70 (higher score indicating greater adherence to management regimen)

    Measured: Baseline/pretest, 3 months/posttest

  11. Change in child quality of life score

    Assessed via Diabetes Quality of Life for Youth questionnaire - Scale of 41-205 (higher score indicating better quality of life)

    Measured: Baseline/pretest, 3 months/posttest

  12. Change in primary caregiver self-efficacy for diabetes management score

    Assessed via Maternal Self-Efficacy for Diabetes Management Scale - Scale of 8-40 (higher score indicating greater self-efficacy for diabetes management)

    Measured: Baseline/pretest, 3 months/posttest

  13. Change in primary caregiver self-efficacy for healthy meal planning and eating score

    Assessed via Parent Mealtime Self-Efficacy Questionnaire - Scale of 11-55 (higher score indicating greater self-efficacy for healthy meal planning and eating)

    Measured: Baseline/pretest, 3 months/posttest

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Dec 2021
  2. Study start5 Sep 2019
  3. Primary completion21 Nov 2019
  4. Study completion21 Nov 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Model description
Single group pretest-poshest study design
Masking
None (open label)
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05160142
Sponsor's protocol ID
STUDY20190718
Acronym
DICE
Status last verified
Dec 2021
First submitted
17 May 2019
Last updated
4 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing DICE in people with Type I Diabetes, run by Case Western Reserve University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

% Change in Hemoglobin A1c (time frame: Baseline/pretest, 3 months/posttest). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in